ClariVest Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

ClariVest Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-28,542	Closed	-$648K	–	751
2016 Q3	$648K	Hold	28,542	–	–	0.02%	357
2016 Q2	$674K	Buy	28,542 +3,800	+15%	+$93.8K	0.02%	327
2016 Q1	$505K	Buy	24,742 +1,023	+4%	+$32.5K	0.02%	358
2015 Q4	$1.22M	Buy	23,719 +5,452	+30%	+$264K	0.03%	265
2015 Q3	$779K	Buy	+18,267	New	+$881K	0.02%	293

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClariVest Asset Management's PTLA Position: Q4 2016 in Review

ClariVest Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2016, closing a stake of 28,542 shares — an estimated $648K sold.

ClariVest Asset Management first reported a position in PTLA in Q3 2015 and held it in 5 quarters. The position peaked at $1.22M in Q4 2015. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

ClariVest Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
ClariVest Asset Management sold 28,542 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $648K.
ClariVest Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
ClariVest Asset Management's Portola Pharmaceuticals, Inc. position peaked at $1.22M in Q4 2015.
150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on ClariVest Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.